A
ABIOMED Inc
LSE:0H7S
ABIOMED Inc
LSE:0H7S
Price:
381.02
USD
0.08%
Market Closed
Market Cap:
$17.2B
Balance Sheet
Balance Sheet Decomposition
ABIOMED Inc
ABIOMED Inc
Balance Sheet Decomposition is not available for
ABIOMED Inc
ABIOMED Inc
Balance Sheet
ABIOMED Inc
ABIOMED Inc
Currency: USD
| Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
10
|
21
|
22
|
48
|
39
|
43
|
121
|
192
|
233
|
133
|
|
| Cash Equivalents |
10
|
21
|
22
|
48
|
39
|
43
|
121
|
192
|
233
|
133
|
|
| Short-Term Investments |
67
|
56
|
110
|
164
|
191
|
319
|
371
|
251
|
351
|
626
|
|
| Total Receivables |
23
|
24
|
32
|
43
|
54
|
70
|
91
|
85
|
97
|
91
|
|
| Accounts Receivables |
23
|
24
|
32
|
43
|
54
|
70
|
91
|
85
|
97
|
91
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
15
|
14
|
17
|
27
|
35
|
50
|
81
|
90
|
81
|
94
|
|
| Other Current Assets |
2
|
3
|
5
|
7
|
8
|
12
|
14
|
18
|
26
|
33
|
|
| Total Current Assets |
117
|
118
|
185
|
288
|
327
|
494
|
677
|
636
|
788
|
976
|
|
| PP&E Net |
7
|
7
|
9
|
23
|
88
|
117
|
145
|
177
|
203
|
212
|
|
| PP&E Gross |
7
|
7
|
9
|
23
|
88
|
117
|
145
|
177
|
203
|
212
|
|
| Accumulated Depreciation |
12
|
14
|
16
|
19
|
20
|
28
|
40
|
58
|
81
|
102
|
|
| Intangible Assets |
0
|
0
|
15
|
15
|
15
|
17
|
15
|
23
|
48
|
46
|
|
| Goodwill |
35
|
38
|
32
|
33
|
31
|
36
|
33
|
32
|
79
|
77
|
|
| Long-Term Investments |
11
|
42
|
14
|
1
|
47
|
50
|
103
|
302
|
366
|
352
|
|
| Other Long-Term Assets |
0
|
1
|
84
|
63
|
43
|
72
|
82
|
47
|
11
|
11
|
|
| Other Assets |
35
|
38
|
32
|
33
|
31
|
36
|
33
|
32
|
79
|
77
|
|
| Total Assets |
170
N/A
|
205
+21%
|
338
+65%
|
424
+25%
|
550
+30%
|
786
+43%
|
1 054
+34%
|
1 217
+15%
|
1 494
+23%
|
1 673
+12%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
8
|
8
|
10
|
9
|
21
|
24
|
32
|
33
|
35
|
35
|
|
| Accrued Liabilities |
13
|
17
|
20
|
26
|
35
|
42
|
45
|
57
|
63
|
74
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
6
|
6
|
9
|
11
|
14
|
20
|
29
|
42
|
32
|
30
|
|
| Total Current Liabilities |
27
|
30
|
39
|
47
|
70
|
85
|
106
|
132
|
129
|
138
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
16
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
6
|
6
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Liabilities |
0
|
0
|
7
|
8
|
12
|
11
|
11
|
18
|
35
|
31
|
|
| Total Liabilities |
33
N/A
|
37
+13%
|
47
+26%
|
55
+18%
|
98
+78%
|
97
-1%
|
118
+21%
|
151
+29%
|
165
+9%
|
170
+3%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Retained Earnings |
258
|
251
|
137
|
99
|
47
|
141
|
400
|
603
|
828
|
965
|
|
| Additional Paid In Capital |
415
|
436
|
465
|
509
|
566
|
620
|
691
|
739
|
801
|
870
|
|
| Treasury Stock |
16
|
17
|
19
|
27
|
47
|
67
|
139
|
265
|
288
|
305
|
|
| Other Equity |
4
|
1
|
17
|
15
|
21
|
4
|
15
|
11
|
11
|
27
|
|
| Total Equity |
137
N/A
|
168
+23%
|
292
+73%
|
369
+26%
|
452
+23%
|
690
+53%
|
937
+36%
|
1 066
+14%
|
1 330
+25%
|
1 503
+13%
|
|
| Total Liabilities & Equity |
170
N/A
|
205
+21%
|
338
+65%
|
424
+25%
|
550
+30%
|
786
+43%
|
1 054
+34%
|
1 217
+15%
|
1 494
+23%
|
1 673
+12%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
39
|
40
|
41
|
43
|
44
|
44
|
45
|
45
|
45
|
46
|
|
Switch to:
Switch to:
See Also
Discover More
